Literature DB >> 7546767

Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury.

W M Maniscalco1, R H Watkins, J N Finkelstein, M H Campbell.   

Abstract

Destruction of pulmonary endothelial cells is characteristic of hyperoxic lung injury. During recovery from hyperoxia, pulmonary endothelial cells proliferate to regenerate the vascular endothelium. Vascular endothelial growth factor (VEGF) is a peptide growth factor that is mitogenic specifically for endothelial cells. We hypothesized that VEGF messenger RNA (mRNA) increases during recovery from acute hyperoxic lung injury. Adult rabbits were exposed to 100% oxygen for 64 h and allowed to recover in air for 0, 1, 3, and 5 days. In situ hybridization showed increased VEGF expression in alveolar epithelial cells beginning at 1 day recovery. By 3 days recovery the message was in alveolar epithelial cells throughout the lung. Compared with alveolar epithelial cells, little or no expression was noted in large vessel endothelial cells, airway cells, or smooth muscle cells. Combined in situ hybridization for VEGF and immunostaining for macrophages and other mesenchymal cells found no VEGF message in those cell types. Isolated alveolar macrophages had no detectable VEGF message. Cells expressing VEGF mRNA were enriched in alveolar type II cell preparations from recovering lung. Double in situ hybridization for VEGF and surfactant protein-C (SP-C) showed co-expression in a population of type II cells, but with an inverse relationship: cells with abundant VEGF mRNA did not have abundant SP-C mRNA. Type II cells in vitro expressed VEGF message, but only when the SP-C message abundance was relatively low. We conclude that alveolar type II cells express increased VEGF mRNA during recovery from acute hyperoxia. These findings are consistent with a role for VEGF in regulating microvascular endothelial repair after oxidant injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7546767     DOI: 10.1165/ajrcmb.13.4.7546767

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  27 in total

1.  Benefits of pre-, pro- and Syn-biotics for lung angiogenesis in malnutritional rats exposed to intermittent hypoxia.

Authors:  Asma Ahmad; Charles L Cai; Dharmendra Kumar; Fayme Cai; Antoni D'Souza; Lawrence Fordjour; Taimur Ahmad; Gloria B Valencia; Jacob V Aranda; Kay D Beharry
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  A protocol for a lung neovascularization model in rodents.

Authors:  Rosemary C Jones; Diane Capen; Bodil Petersen; Rakesh K Jain; Dan G Duda
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 3.  Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease.

Authors:  Bernard Thébaud; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

4.  Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury.

Authors:  Arwin M Valencia; Maria A Abrantes; Jamal Hasan; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2018-11

5.  IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.

Authors:  J Corne; G Chupp; C G Lee; R J Homer; Z Zhu; Q Chen; B Ma; Y Du; F Roux; J McArdle; A B Waxman; J A Elias
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 6.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

7.  Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor.

Authors:  Su Jin Cho; Caroline L S George; Jeanne M Snyder; Michael J Acarregui
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-01       Impact factor: 6.914

8.  Vascular endothelial growth factor in bronchoalveolar lavage fluid in sulfur mustard exposed lung patients.

Authors:  Ali Karami; Mostafa Ghanei; Farshid Alaeddini; Mohammad Javad Soltanpour; Mobin Yassini; Ali Amini Harandi
Journal:  Oman Med J       Date:  2011-03

Review 9.  Evidence-based recommendations for the use of topical oxygen therapy in the treatment of lower extremity wounds.

Authors:  Gayle M Gordillo; Chandan K Sen
Journal:  Int J Low Extrem Wounds       Date:  2009-06       Impact factor: 2.057

10.  Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS.

Authors:  R Zhai; M N Gong; W Zhou; T B Thompson; P Kraft; L Su; D C Christiani
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.